Related Experiment Videos
Platelet-derived growth factor expression in mesangial proliferative glomerulonephritis.
L Gesualdo1, M Pinzani, J J Floriano
1Institute of Pathology, Veterans Administration Hospital, Case Western Reserve University, Cleveland, Ohio.
Summary
Platelet-derived growth factor (PDGF) drives mesangial cell proliferation in proliferative glomerulonephritis. This study demonstrates increased PDGF expression in animal models and human kidney disease, linking it to kidney damage.
Area of Science:
- Nephrology
- Molecular Biology
- Pathology
Background:
- Proliferative glomerular diseases cause renal failure via mesangial cell proliferation and matrix expansion.
- Platelet-derived growth factor (PDGF) is known to stimulate mesangial cell proliferation.
- Previous studies on PDGF's role were limited to in vitro settings.
Purpose of the Study:
- To investigate the in vivo role of PDGF in proliferative glomerulonephritides.
- To examine PDGF expression in animal models of IgA nephropathy.
- To correlate PDGF levels with specific histologic patterns and disease severity.
Main Methods:
- Utilized two animal models of IgA nephropathy with distinct glomerular injury patterns.
- Assessed PDGF and PDGF B-chain mRNA expression using immunohistochemistry and solution hybridization.
- Examined PDGF expression in human glomerulonephritis cases.
Main Results:
- Demonstrated increased PDGF and PDGF B-chain mRNA expression in diseased mouse kidneys.
- Localized increased PDGF primarily to the glomerular mesangium.
- Found a correlation between elevated PDGF expression, glomerular hypercellularity, and clinical disease features.
Conclusions:
- PDGF is upregulated in vivo during proliferative glomerulonephritis.
- Increased PDGF expression is associated with mesangial cell proliferation and disease severity.
- PDGF is implicated as a key factor in the pathogenesis of proliferative glomerulonephritides.